Drug Pipeline

CFI-400945 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05601440 Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2… Breast Cancer Recruiting
NCT03624543 CFI-400945 in Patients With Advanced/Metastatic Breast Cancer Breast Cancer Active, Not Recruiting
NCT04176848 CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer Breast Cancer Active, Not Recruiting
Sponsors Running CFI-400945 Trials
Canadian Cancer Trials Group (3)
Disease Areas
Breast Cancer (3)
Get alerts when CFI-400945 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free